OPEN MINDS The Behavioral Health & Social Service Industry Analyst

Industry News

Sandoz Pharmaceuticals Corporation announced a new set of rules for doctors, hospitals, and pharmacists to devise their own patient blood monitoring systems to facilitate the use of Clozaril. Since Clozaril came on the market in February, 1990, it has been available only along with Sandoz’s proprietary Clozaril Patient Monitoring System, under which patients undergo weekly blood tests as a condition for getting a weekly supply of the medication.

Under the new system, Sandoz will require doctors . . .

Restricted Content
You must be an Elite member to view this resource.
Log In | Sign up or learn more about membership options.

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!